• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 储存库细胞的免疫靶向:消除策略和治愈的途径。

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure.

机构信息

Infectious Disease Division, Brigham and Women's Hospital, Boston, MA, USA.

Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.

出版信息

Nat Rev Microbiol. 2024 Jun;22(6):328-344. doi: 10.1038/s41579-024-01010-8. Epub 2024 Feb 9.

DOI:10.1038/s41579-024-01010-8
PMID:38337034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11131351/
Abstract

Successful approaches for eradication or cure of HIV-1 infection are likely to include immunological mechanisms, but remarkably little is known about how human immune responses can recognize and interact with the few HIV-1-infected cells that harbour genome-intact viral DNA, persist long term despite antiretroviral therapy and represent the main barrier to a cure. For a long time regarded as being completely shielded from host immune responses due to viral latency, these cells do, on closer examination with single-cell analytic techniques, display discrete footprints of immune selection, implying that human immune responses may be able to effectively engage and target at least some of these cells. The failure to eliminate rebound-competent virally infected cells in the majority of persons likely reflects the evolution of a highly selected pool of reservoir cells that are effectively camouflaged from immune recognition or rely on sophisticated approaches for resisting immune-mediated killing. Understanding the fine-tuned interplay between host immune responses and viral reservoir cells will help to design improved interventions that exploit the immunological vulnerabilities of HIV-1 reservoir cells.

摘要

成功根除或治愈 HIV-1 感染的方法可能包括免疫机制,但人们对人类免疫反应如何识别和与少数携带完整基因组病毒 DNA 的 HIV-1 感染细胞相互作用知之甚少,这些细胞尽管接受了抗逆转录病毒治疗,但仍能长期存在,是治愈的主要障碍。这些细胞由于病毒潜伏而长期被认为完全免受宿主免疫反应的影响,但通过单细胞分析技术的更仔细检查,它们确实显示出免疫选择的离散痕迹,这意味着人类免疫反应可能能够有效地参与并针对这些细胞中的至少一些。在大多数人中未能消除具有反弹能力的病毒感染细胞,可能反映了储备细胞的高度选择池的演变,这些细胞有效地逃避了免疫识别,或者依靠复杂的方法来抵抗免疫介导的杀伤。了解宿主免疫反应和病毒储备细胞之间的精细相互作用将有助于设计改进的干预措施,利用 HIV-1 储备细胞的免疫脆弱性。

相似文献

1
Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure.HIV-1 储存库细胞的免疫靶向:消除策略和治愈的途径。
Nat Rev Microbiol. 2024 Jun;22(6):328-344. doi: 10.1038/s41579-024-01010-8. Epub 2024 Feb 9.
2
Targeting the Latent Reservoir for HIV-1.针对 HIV-1 的潜伏储库。
Immunity. 2018 May 15;48(5):872-895. doi: 10.1016/j.immuni.2018.04.030.
3
Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators.激活潜伏的 HIV-1 T 细胞储库的组合:先天免疫和表观遗传调节剂。
J Virol. 2019 Oct 15;93(21). doi: 10.1128/JVI.01194-19. Print 2019 Nov 1.
4
Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.HIV-1储存库:在抗病毒免疫反应和抗逆转录病毒疗法存在的情况下病毒持续存在的机制
Annu Rev Immunol. 2000;18:665-708. doi: 10.1146/annurev.immunol.18.1.665.
5
Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.1 型程序化树突状细胞驱动抗原特异性潜伏逆转和持续 HIV-1 的免疫消除。
EBioMedicine. 2019 May;43:295-306. doi: 10.1016/j.ebiom.2019.03.077. Epub 2019 Apr 2.
6
HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir .HIV-1 特异性嵌合抗原受体 T 细胞无法识别和清除滤泡树突状细胞 HIV 储存库。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00190-20.
7
Phenotypic signatures of immune selection in HIV-1 reservoir cells.HIV-1 储库细胞中免疫选择的表型特征。
Nature. 2023 Feb;614(7947):309-317. doi: 10.1038/s41586-022-05538-8. Epub 2023 Jan 4.
8
Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir.体内 HIV CD4 T 细胞储存库的非刺激表型分析。
Elife. 2020 Sep 29;9:e60933. doi: 10.7554/eLife.60933.
9
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.在用帕比司他进行潜伏逆转治疗期间,先天免疫活性与CD4 T细胞相关的HIV-1 DNA下降相关。
J Virol. 2015 Oct;89(20):10176-89. doi: 10.1128/JVI.01484-15. Epub 2015 Jul 29.
10
Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure.区分肠道相关淋巴组织中的免疫细胞靶点以实现HIV治愈
AIDS Res Hum Retroviruses. 2017 Nov;33(S1):S40-S58. doi: 10.1089/AID.2017.0153.

引用本文的文献

1
Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sites.免疫检查点抑制剂的使用对HIV储存库的影响与前病毒序列有关,而与整合位点无关。
Sci Rep. 2025 Aug 28;15(1):31726. doi: 10.1038/s41598-025-15349-2.
2
Motivations, acceptability and ethical considerations for interventional HIV cure research at the end of life: perspectives from long-term survivors of HIV in the United States.临终时HIV干预性治愈研究的动机、可接受性及伦理考量:来自美国HIV长期存活者的观点
BMC Med Ethics. 2025 Aug 23;26(1):112. doi: 10.1186/s12910-025-01253-x.
3
Aquarius helicase facilitates HIV-1 integration into R-loop enriched genomic regions.

本文引用的文献

1
Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir.Tat RNA 纳米颗粒可有效逆转潜伏,实现 HIV-1 储存库的多组学分析。
Nat Commun. 2023 Dec 18;14(1):8397. doi: 10.1038/s41467-023-44020-5.
2
Viral and host mediators of non-suppressible HIV-1 viremia.非抑制性 HIV-1 病毒血症的病毒和宿主介质。
Nat Med. 2023 Dec;29(12):3212-3223. doi: 10.1038/s41591-023-02611-1. Epub 2023 Nov 13.
3
Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy.抗逆转录病毒治疗期间大脑中完整 HIV-1 前病毒的持续存在。
水瓶座解旋酶促进HIV-1整合到富含R环的基因组区域。
Nat Microbiol. 2025 Aug 20. doi: 10.1038/s41564-025-02089-2.
4
No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.在长期病毒抑制的基于多替拉韦的抗逆转录病毒治疗个体中,HIV储存库与炎症之间无关联。
Front Immunol. 2025 Jul 28;16:1628086. doi: 10.3389/fimmu.2025.1628086. eCollection 2025.
5
Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities.HIV感染者的淋巴细胞增殖:致癌途径、诊断挑战及新的治疗机遇
Cancers (Basel). 2025 Jun 22;17(13):2088. doi: 10.3390/cancers17132088.
6
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.“乘客”假说在HIV病毒库持久性及治愈方面的应用与局限性
J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4.
7
Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1.接受围产期获得性HIV-1长期抗逆转录病毒治疗的个体中不同的病毒储存库和免疫特征。
Cell Rep Med. 2025 Jun 17;6(6):102150. doi: 10.1016/j.xcrm.2025.102150. Epub 2025 May 29.
8
Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches.HIV相关淋巴瘤发生的病理机制:新型靶向治疗方法。
Cells. 2025 May 13;14(10):705. doi: 10.3390/cells14100705.
9
Genetic Variants in the NOD-like Receptor Signaling Pathway Are Associated with HIV-1/AIDS in a Northern Chinese Population.核苷酸结合寡聚化结构域样受体信号通路中的基因变异与中国北方人群的HIV-1/艾滋病相关。
Int J Mol Sci. 2025 Apr 8;26(8):3484. doi: 10.3390/ijms26083484.
10
Heat shock protein 90 is a chaperone regulator of HIV-1 latency.热休克蛋白90是HIV-1潜伏状态的一种伴侣调节因子。
PLoS Pathog. 2025 Apr 1;21(4):e1012524. doi: 10.1371/journal.ppat.1012524. eCollection 2025 Apr.
Elife. 2023 Nov 8;12:RP89837. doi: 10.7554/eLife.89837.
4
Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence.单细胞表观遗传、转录和蛋白质谱分析潜伏和活跃的 HIV-1 储库表明,IKZF3 促进了 HIV-1 的持续存在。
Immunity. 2023 Nov 14;56(11):2584-2601.e7. doi: 10.1016/j.immuni.2023.10.002. Epub 2023 Nov 2.
5
AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques.AZD5582 联合 SIV 特异性抗体可减少抗逆转录病毒治疗抑制的猕猴淋巴结中的病毒储存库。
Nat Med. 2023 Oct;29(10):2535-2546. doi: 10.1038/s41591-023-02570-7. Epub 2023 Oct 2.
6
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.维奈托克(Venetoclax)单独使用和与 BH3 模拟物 S63845 联合使用,可耗尽 HIV-1 潜伏感染细胞,并延缓人源化小鼠的病毒反弹。
Cell Rep Med. 2023 Sep 19;4(9):101178. doi: 10.1016/j.xcrm.2023.101178. Epub 2023 Aug 30.
7
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy.尽管已经进行了几十年的抗逆转录病毒治疗,但可诱导、感染性 HIV-1 的潜伏储库并未减少。
J Clin Invest. 2023 Sep 1;133(17):e171554. doi: 10.1172/JCI171554.
8
Impact of misclassified defective proviruses on HIV reservoir measurements.错误分类的缺陷前病毒对 HIV 储存库测量的影响。
Nat Commun. 2023 Jul 13;14(1):4186. doi: 10.1038/s41467-023-39837-z.
9
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller.后治疗控制者体内的抗 V1/V3-聚糖广谱 HIV-1 中和抗体。
Cell Host Microbe. 2023 Aug 9;31(8):1275-1287.e8. doi: 10.1016/j.chom.2023.06.006. Epub 2023 Jul 10.
10
Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana.在博茨瓦纳,广泛中和抗体治疗可维持具有良好储存特征的儿童的 HIV 抑制。
Sci Transl Med. 2023 Jul 5;15(703):eadh0004. doi: 10.1126/scitranslmed.adh0004.